Life Sciences Voice

Life Sciences Voice Life Sciences Voice is the leading resource for life sciences executives to get crucial insights

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Upasana Kamineni Konidela believes in creating sustainable businesses rooted in social welfare that create a deep, long-...
09/25/2025

Upasana Kamineni Konidela believes in creating sustainable businesses rooted in social welfare that create a deep, long-term impact. She is a third-generation entrepreneur and philanthropist from the Apollo Hospitals family in India. Her heritage of healing and building community infrastructure is reflected in her business ventures and her giving practices. UrLife is built on the idea of urban wellness and productivity, while the Apollo Foundation is based on founder-chairperson of Apollo Hospitals, Dr Prathap C.Reddy’s model of womb-to-tomb care. Upasana’s professional life is an extension of herself, her values, and the way she lives her life. She believes that the world can and that it is possible to .

A Session Marked by Disorientation and DoubtIn a very stressful and at times disorienting session of the Centers for Dis...
09/25/2025

A Session Marked by Disorientation and Doubt

In a very stressful and at times disorienting session of the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP), a sequence of front-and-back-and-forth votes cast doubt on the issue of transparency, decision-making, and trust inside the committee. This meeting, which was shortly after a reshuffling of the committee by Robert F. Kennedy Jr., ended with mixed decisions of the Merck combined measles, mumps, rubella, and varicella (MMRV) vaccine.

Novo Nordisk’s Kyinsu for Type 2 DiabetesA year after Novo Nordisk withdrew its U.S. application for IcoSema as a treatm...
09/25/2025

Novo Nordisk’s Kyinsu for Type 2 Diabetes

A year after Novo Nordisk withdrew its U.S. application for IcoSema as a treatment for type 2 diabetes, the company has gained support for the combination therapy in Europe. The Committee for Medicinal Products for Human Use (CHMP) has recommended once-weekly Kyinsu, the European name for the therapy, for patients with type 2 diabetes who cannot adequately control blood sugar with basal insulin or glucagon-like peptide 1 (GLP-1) receptor agonists.

Roche has officially entered the metabolic dysfunction-related steatohepatitis (MASH) space by acquiring 89bio and its p...
09/25/2025

Roche has officially entered the metabolic dysfunction-related steatohepatitis (MASH) space by acquiring 89bio and its promising phase-3 candidate for fatty liver disease.

09/25/2025

Roche Reports Positive Phase 3 Results for Breast Cancer Drug Giredestrant, Pfizer agrees to a $4.9 billion upfront purchase of Metsera to strengthen obesity portfolio.

09/22/2025

Eli Lilly and Company to Invest $5 Billion in Virginia API Plant, First of Four New U.S. Manufacturing Mega Sites.

Philippe Martin is the Chief R&D Officer of Viatris. He joined the company in September 2023. Philippe is a highly exper...
09/18/2025

Philippe Martin is the Chief R&D Officer of Viatris. He joined the company in September 2023. Philippe is a highly experienced R&D leader with demonstrated success in building and leading high-performing R&D organizations. He has more than 25 years of experience developing and commercialising innovative and transformational therapies across multiple therapeutic areas and modalities ranging from small molecules to highly innovative biologics and cell therapies.
Before joining Viatris, Philippe was Chief of R&D at BioAtla, Inc., a global biotechnology company that develops novel therapies for cancer treatment. Philippe previously served at Celgene for nearly 10 years where his roles expanded from Executive Director, Project Leadership – in which he led development and commercialisation of the blockbuster drugs Otezla® and Zeposia® – to Corporate Vice President, in which he oversaw the company pipeline in early and late development in the fields of inflammation and immunology, neurology, oncology, hepatology and gastroenterology, including the ex*****on of large Phase 3 clinical studies. Prior to Celgene, Philippe held multiple positions of increasing responsibility at Schering-Plough Research Institute and Aventis & Solvay.
Philippe earned a master’s degree in organic chemistry from Pierre and Pierre and Marie Curie University in Paris and a Master of Business Administration from emlyon business school in Lyon, France.

For any concern Please DM

09/18/2025

Pfizer's Inclacumab Falls to Meet Endpoint in Phase 3 Sickle Cell Trial

Life Sciences Voice Rising Stars Award 2025 Winner SpotlightCongratulations to Steve Fox, VP Sales at Zynex Medical on b...
09/01/2025

Life Sciences Voice Rising Stars Award 2025 Winner Spotlight

Congratulations to Steve Fox, VP Sales at Zynex Medical on being named a 2025 Rising Stars Award winner!
Steve is making a remarkable impact in the life sciences industry and exemplifies the innovation, leadership, and vision that this award celebrates.

Join us in celebrating Steve and explore the full list of LSV Rising Stars here: https://lifescivoice.com/lsv-rising-stars-award-2025/

Life Sciences Voice Rising Stars Award 2025 Winner SpotlightCongratulations to Nicole Hengst, Vice President, Global Bus...
09/01/2025

Life Sciences Voice Rising Stars Award 2025 Winner Spotlight

Congratulations to Nicole Hengst, Vice President, Global Business Intelligence at Azurity Pharmaceuticals on being named a 2025 Rising Stars Award winner!
Nicole is making a remarkable impact in the life sciences industry and exemplifies the innovation, leadership, and vision that this award celebrates.

Join us in celebrating Nicole and explore the full list of LSV Rising Stars here: https://lifescivoice.com/lsv-rising-stars-award-2025/

Life Sciences Voice Rising Stars Award 2025 Winner SpotlightCongratulations to Ajay Sharma, Vice President, eCommerce & ...
08/27/2025

Life Sciences Voice Rising Stars Award 2025 Winner Spotlight

Congratulations to Ajay Sharma, Vice President, eCommerce & Omnichannel at Bayer, on being named a 2025 Rising Stars Award winner!
Ajay is making a remarkable impact in the life sciences industry and exemplifies the innovation, leadership, and vision that this award celebrates.

Join us in celebrating Ajay and explore the full list of LSV Rising Stars here: https://lnkd.in/d6WWurUv

Life Sciences Voice Rising Stars Award 2025 Winner SpotlightCongratulations to Dr. Chureen Carter, PharmD, MS, Vice Pres...
08/27/2025

Life Sciences Voice Rising Stars Award 2025 Winner Spotlight

Congratulations to Dr. Chureen Carter, PharmD, MS, Vice President, eCommerce & Omnichannel at Johnson & Johnson Innovative Medicine, on being named a 2025 Rising Stars Award winner!
Dr. Chureen is making a remarkable impact in the life sciences industry and exemplifies the innovation, leadership, and vision that this award celebrates.

Join us in celebrating Dr. Chureen and explore the full list of LSV Rising Stars here: https://lifescivoice.com/lsv-rising-stars-award-2025/

Address

New York, NY

Website

Alerts

Be the first to know and let us send you an email when Life Sciences Voice posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Life Sciences Voice:

Shortcuts

Share

Category